IND & IMPD Enabling Developability Roadmap
Drug discovery and development is a complex and iterative process that involves the identification, design, development, testing, and approval of new pharmaceutical drugs for use in patients. It encompasses a series of scientific, regulatory, and commercial activities aimed at discovering and bringing safe and effective medicines to the market.
A key milestone in this process is candidate selection when a decision is taken to invest in a single molecule and transition the program from discovery into development. This transition prompts a number of activities to facilitate drug development, one of which is an assessment of potential sources of issues or delays in subsequent development. At Symeres, we designed our proprietary Developability Roadmap package to provide you with the information you need to enter development with a clear plan of action.
Download Whitepaper
Fill out the form below to receive your pdf.
